Cargando…
Mesenchymal Stem Cells in Treatment of Spinal Cord Injury and Amyotrophic Lateral Sclerosis
Preclinical and clinical studies with various stem cells, their secretomes, and extracellular vesicles (EVs) indicate their use as a promising strategy for the treatment of various diseases and tissue defects, including neurodegenerative diseases such as spinal cord injury (SCI) and amyotrophic late...
Autores principales: | Sykova, Eva, Cizkova, Dasa, Kubinova, Sarka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8290345/ https://www.ncbi.nlm.nih.gov/pubmed/34295897 http://dx.doi.org/10.3389/fcell.2021.695900 |
Ejemplares similares
-
Corrigendum: Mesenchymal Stem Cells in Treatment of Spinal Cord Injury and Amyotrophic Lateral Sclerosis
por: Sykova, Eva, et al.
Publicado: (2021) -
Regenerative medicine for the treatment of spinal cord injury: more than just promises?
por: Pêgo, Ana Paula, et al.
Publicado: (2012) -
Highly efficient magnetic targeting of mesenchymal stem cells in spinal cord injury
por: Vaněček, Václav, et al.
Publicado: (2012) -
Exosomal Proteins and miRNAs as Mediators of Amyotrophic Lateral Sclerosis
por: Chen, Qiao Yi, et al.
Publicado: (2021) -
Extracellular Vesicles as Innovative Treatment Strategy for Amyotrophic Lateral Sclerosis
por: Wang, Ke, et al.
Publicado: (2021)